MX2015016771A - Compuestos de carbazol carboxamida utiles como inhibidores de cinasa. - Google Patents
Compuestos de carbazol carboxamida utiles como inhibidores de cinasa.Info
- Publication number
- MX2015016771A MX2015016771A MX2015016771A MX2015016771A MX2015016771A MX 2015016771 A MX2015016771 A MX 2015016771A MX 2015016771 A MX2015016771 A MX 2015016771A MX 2015016771 A MX2015016771 A MX 2015016771A MX 2015016771 A MX2015016771 A MX 2015016771A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- kinase inhibitors
- compounds useful
- carboxamide compounds
- formula
- Prior art date
Links
- GFHHIWFKWFBNRU-UHFFFAOYSA-N 9h-carbazole-1-carboxamide Chemical class C12=CC=CC=C2NC2=C1C=CC=C2C(=O)N GFHHIWFKWFBNRU-UHFFFAOYSA-N 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 abstract 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361839130P | 2013-06-25 | 2013-06-25 | |
| PCT/US2014/043980 WO2014210087A1 (en) | 2013-06-25 | 2014-06-25 | Carbazole carboxamide compounds useful as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015016771A true MX2015016771A (es) | 2016-03-31 |
Family
ID=51210832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015016771A MX2015016771A (es) | 2013-06-25 | 2014-06-25 | Compuestos de carbazol carboxamida utiles como inhibidores de cinasa. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9714234B2 (enExample) |
| EP (1) | EP3013815B1 (enExample) |
| JP (1) | JP6353530B2 (enExample) |
| KR (1) | KR102345381B1 (enExample) |
| CN (1) | CN105473573B (enExample) |
| AU (1) | AU2014302550A1 (enExample) |
| BR (1) | BR112015031432A2 (enExample) |
| CA (1) | CA2916504A1 (enExample) |
| EA (1) | EA025863B1 (enExample) |
| IL (1) | IL243295A0 (enExample) |
| MX (1) | MX2015016771A (enExample) |
| SG (1) | SG11201510028PA (enExample) |
| WO (1) | WO2014210087A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20171239A1 (es) | 2014-10-24 | 2017-08-24 | Bristol Myers Squibb Co | Derivados de carbazol |
| AU2015335783B2 (en) | 2014-10-24 | 2019-10-03 | Bristol-Myers Squibb Company | Tricyclic atropisomer compounds |
| HUE050706T2 (hu) | 2014-10-24 | 2020-12-28 | Bristol Myers Squibb Co | Indol karboxamid vegyületek, amelyek hasznosak kináz inhibitorokként |
| CN105802100A (zh) * | 2016-04-22 | 2016-07-27 | 宁波硫华聚合物有限公司 | 橡胶促进剂粘合剂六甲氧基甲基蜜胺预分散母胶粒及其制备方法 |
| CN105670057A (zh) * | 2016-04-25 | 2016-06-15 | 无锡智谷锐拓技术服务有限公司 | 一种耐油橡胶的制备方法 |
| CN105694150A (zh) * | 2016-04-25 | 2016-06-22 | 无锡智谷锐拓技术服务有限公司 | 一种耐油橡胶 |
| CN105907150A (zh) * | 2016-06-02 | 2016-08-31 | 扬州兰都塑料科技有限公司 | 一种电缆涂料用阻燃剂 |
| CN106084903A (zh) * | 2016-06-02 | 2016-11-09 | 扬州兰都塑料科技有限公司 | 一种电缆外部涂覆的水性防火涂料的制备方法 |
| CN106045972B (zh) * | 2016-06-03 | 2018-11-16 | 中山大学 | 咔唑-利凡斯的明二联体及其药物组合物和应用 |
| US12421230B2 (en) | 2020-02-03 | 2025-09-23 | Bristol-Myers Squibb Company | Tricyclic heteroaryl compounds useful as IRAK4 inhibitors |
| US20240100172A1 (en) | 2020-12-21 | 2024-03-28 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
| CN115232061B (zh) * | 2021-09-18 | 2024-01-30 | 山西紫罗蓝新材料科技有限公司 | 一种3-硝基-9-乙基咔唑粗产物的提取工艺 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
| CA2140722A1 (en) | 1994-01-24 | 1995-07-25 | Joseph A. Jakubowski | Beta-carboline thromboxane synthase inhibitors |
| WO2005014599A1 (en) | 2003-06-04 | 2005-02-17 | Cellular Genomics, Inc. | Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| US7393848B2 (en) | 2003-06-30 | 2008-07-01 | Cgi Pharmaceuticals, Inc. | Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds |
| US20050288295A1 (en) | 2003-11-11 | 2005-12-29 | Currie Kevin S | Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
| EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2006053121A2 (en) | 2004-11-10 | 2006-05-18 | Cgi Pharmaceuticals, Inc. | Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| EA014956B1 (ru) | 2004-12-17 | 2011-04-29 | ГЛЕНМАРК ФАРМАСЬЮТИКАЛС Эс.Эй. | Гетероциклические соединения, применяемые для лечения воспалительных и аллергических нарушений |
| CA2601628C (en) | 2005-03-10 | 2014-05-13 | Cgi Pharmaceuticals, Inc. | Certain substituted amides, method of making, and method of use thereof |
| US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US7723336B2 (en) | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| JP5249772B2 (ja) | 2005-11-22 | 2013-07-31 | メルク・シャープ・アンド・ドーム・コーポレーション | キナーゼの阻害剤として有用な三環式化合物 |
| EP2068849A2 (en) | 2006-09-11 | 2009-06-17 | CGI Pharmaceuticals, Inc. | Kinase inhibitors, and methods of using and identifying kinase inhibitors |
| AU2007297221B2 (en) | 2006-09-11 | 2012-11-08 | Mylan Laboratories Limited | Dibenzofuran derivatives as inhibitors of PDE-4 and PDE-10 |
| US20090062251A1 (en) | 2007-08-17 | 2009-03-05 | Astrazeneca Ab | Novel Compounds 002 |
| EP2231143B1 (en) | 2007-12-13 | 2013-07-03 | Merck Sharp & Dohme Corp. | 5H-pyrido[4,3-b]indoles as INHIBITORS OF JANUS KINASES |
| PL2247558T5 (pl) | 2008-02-14 | 2024-10-14 | Eli Lilly And Company | Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych |
| GB0809360D0 (en) | 2008-05-22 | 2008-07-02 | Isis Innovation | Calcium modulation |
| CA2725512C (en) * | 2008-07-18 | 2016-06-28 | F. Hoffmann-La Roche Ag | Novel phenylimidazopyrazines |
| EP2151441A1 (en) | 2008-08-06 | 2010-02-10 | Julius-Maximilians-Universität Würzburg | Beta-carbolin-derivates as substrates for an enzyme |
| CN102325753B (zh) | 2008-12-19 | 2014-09-10 | 百时美施贵宝公司 | 用作激酶抑制剂的咔唑甲酰胺化合物 |
| CN101475571B (zh) | 2009-01-21 | 2011-06-22 | 中国药科大学 | β-咔啉类细胞周期蛋白依赖性激酶2抑制剂及其用途 |
| US8242260B2 (en) | 2009-08-28 | 2012-08-14 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
| WO2011159857A1 (en) * | 2010-06-16 | 2011-12-22 | Bristol-Myers Squibb Company | Carboline carboxamide compounds useful as kinase inhibitors |
| EP2455378A1 (en) | 2010-11-03 | 2012-05-23 | Philip Morris Products S.A. | Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| BR112013011991A2 (pt) | 2010-11-15 | 2016-08-30 | Viiv Healthcare Uk Ltd | composto, composição farmacêutica, uso de um composto, método de tratamento, produto, e kit. |
| AU2012257802A1 (en) | 2011-05-17 | 2013-10-31 | F. Hoffmann-La Roche Ag | Inhibitors of Bruton's tyrosine kinase |
| UY35625A (es) | 2013-06-25 | 2014-12-31 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos como inhibidores de quinasa |
-
2014
- 2014-06-25 CN CN201480046669.2A patent/CN105473573B/zh not_active Expired - Fee Related
- 2014-06-25 AU AU2014302550A patent/AU2014302550A1/en not_active Abandoned
- 2014-06-25 JP JP2016523870A patent/JP6353530B2/ja not_active Expired - Fee Related
- 2014-06-25 MX MX2015016771A patent/MX2015016771A/es unknown
- 2014-06-25 CA CA2916504A patent/CA2916504A1/en not_active Abandoned
- 2014-06-25 SG SG11201510028PA patent/SG11201510028PA/en unknown
- 2014-06-25 WO PCT/US2014/043980 patent/WO2014210087A1/en not_active Ceased
- 2014-06-25 KR KR1020167001634A patent/KR102345381B1/ko not_active Expired - Fee Related
- 2014-06-25 US US14/392,355 patent/US9714234B2/en active Active
- 2014-06-25 BR BR112015031432A patent/BR112015031432A2/pt not_active Application Discontinuation
- 2014-06-25 EP EP14740096.4A patent/EP3013815B1/en not_active Not-in-force
- 2014-06-25 EA EA201690012A patent/EA025863B1/ru not_active IP Right Cessation
-
2015
- 2015-12-22 IL IL243295A patent/IL243295A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3013815A1 (en) | 2016-05-04 |
| EA025863B1 (ru) | 2017-02-28 |
| BR112015031432A2 (pt) | 2017-07-25 |
| KR102345381B1 (ko) | 2021-12-29 |
| SG11201510028PA (en) | 2016-01-28 |
| CA2916504A1 (en) | 2014-12-31 |
| EA201690012A1 (ru) | 2016-05-31 |
| US9714234B2 (en) | 2017-07-25 |
| US20160200710A1 (en) | 2016-07-14 |
| CN105473573B (zh) | 2018-03-16 |
| WO2014210087A1 (en) | 2014-12-31 |
| JP6353530B2 (ja) | 2018-07-04 |
| AU2014302550A1 (en) | 2016-02-11 |
| IL243295A0 (en) | 2016-02-29 |
| CN105473573A (zh) | 2016-04-06 |
| KR20160022890A (ko) | 2016-03-02 |
| JP2016523908A (ja) | 2016-08-12 |
| EP3013815B1 (en) | 2017-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015016771A (es) | Compuestos de carbazol carboxamida utiles como inhibidores de cinasa. | |
| PH12020500265A1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| MY176631A (en) | Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors | |
| TN2017000158A1 (en) | Carbazole derivatives | |
| MX2022005290A (es) | Compuestos heterociclicos como inmunomoduladores. | |
| MY192354A (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| MY199220A (en) | Heterocyclic compounds as immunomodulators | |
| MX2017005060A (es) | Compuestos atropisomeros triciclicos. | |
| EA201590353A1 (ru) | Способы лечения болезни альцгеймера и фармацевтические композиции | |
| EA201600636A1 (ru) | 2-амино-6-метил-4,4а,5,6-тетрагидропирано[3,4-d][1,3]тиазин-8а(8н)-ил-1,3-тиазол-4-ил амиды | |
| MX2020012978A (es) | Sales de sepiapterina farmacéuticamente aceptables. | |
| WO2016109217A3 (en) | Btk inhibitors | |
| BR112017009583A2 (pt) | 2-amino-6-(difluorometil)-5,5-difluoro-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 | |
| WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
| EA201790315A1 (ru) | Модуляторы x-рецепторов печени | |
| MX357888B (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
| CA3007110C (en) | HETEROCYCLIC COMPOUNDS AND THEIR USES | |
| EA201791398A1 (ru) | Производные фумагиллола | |
| ZA202300107B (en) | Pharmaceutically acceptable salts of sepiapterin |